Company / Inventory
Amgen Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$6.2B
FY2025
5-year range
$4.1B / $9.5B
FY2021-FY2025
Trend
-11.0%
vs FY2024
Sector context
#5 of 108
Health Care
What the data says
Among 108 Health Care companies, Amgen is in the top 5% for inventory. Declined from $9.5B to $6.2B over the past 2 years.
Based on SEC 10-K filings.
$6.2B in FY2025 with a 5-year CAGR of +9.8%. Top quartile in the Health Care sector.
Declined from $9.5B to $6.2B over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +8.1%
- 5-Year CAGR
- +9.8%
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 108This company $6.2B Sector average $862.4M
▼
+621.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +9.8%, indicating consistent growth.
- In FY2025, inventory decreased 11.0% year-over-year.
- Ranks #5 out of 108 companies in the Health Care sector.
- Peak inventory was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.2B | -11.0% |
| FY2024 | $7.0B | -26.5% |
| FY2023 | $9.5B | +93.1% |
| FY2022 | $4.9B | +20.7% |
| FY2021 | $4.1B | +5.0% |
| FY2020 | $3.9B | +8.6% |
| FY2019 | $3.6B | +21.9% |
| FY2018 | $2.9B | +3.7% |
| FY2017 | $2.8B | +3.2% |
| FY2016 | $2.7B | +12.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026